Literature DB >> 19009182

Clinical, epidemiological and laboratory aspects of patients with American cutaneous leishmaniasis in the State of Pernambuco.

Luiza de Campos Reis1, Maria Edileuza Felinto de Brito, Ericka Lima de Almeida, Simone Marta Félix, Angela Cristina Rapela Medeiros, Cláudio Júlio Silva, Valéria Rêgo Alves Pereira.   

Abstract

The diagnosis for American cutaneous leishmaniasis is based on an association of clinical, epidemiological and laboratory characteristics. The present study identified the circulating species of Leishmania in the State of Pernambuco, described its clinical-epidemiological characteristics and diagnosed the disease. Nineteen patients presenting active lesions who had been diagnosed through clinical evaluation and laboratory tests were selected. The tests included direct investigation, in vitro culturing, Montenegro skin test, indirect immunofluorescence and polymerase chain reaction. The Montenegro Skin Test showed positive results in 89% of the patients; indirect immunofluorescence, in 79%; direct investigation, in 58%; and polymerase chain reaction in 75%. Seven Leishmania (Viannia) braziliensis samples were isolated from these patients and were characterized by means of specific monoclonal antibodies. These data confirm that a combination of different diagnosis techniques is needed in order to obtain efficient results and that, so far, Leishmania (Viannia) braziliensis is the only species responsible for American cutaneous leishmaniasis infection in Pernambuco. Thus, it is essential to identify the parasite species involved in cases of human disease in an endemic area in order to determine the clinical and epidemiological characteristics, especially with regard to diagnosis, therapy development and disease prognosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19009182     DOI: 10.1590/s0037-86822008000500001

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  9 in total

1.  Diagnosing Cutaneous leishmaniasis using Fluorescence in Situ Hybridization: the Sri Lankan Perspective.

Authors:  Thilini Dilhara Jayasena Kaluarachchi; Manjula Manoji Weerasekera; Andrew J McBain; Shalindra Ranasinghe; Renu Wickremasinghe; Surangi Yasawardene; Nisal Jayanetti; Rajitha Wickremasinghe
Journal:  Pathog Glob Health       Date:  2019-08-20       Impact factor: 2.894

2.  Old World cutaneous leishmaniasis: diagnosis and treatment.

Authors:  Abderrahmen Masmoudi; Wala Hariz; Slaheddine Marrekchi; Mariem Amouri; Hamida Turki
Journal:  J Dermatol Case Rep       Date:  2013-06-30

Review 3.  Complementary exams in the diagnosis of American tegumentary leishmaniasis.

Authors:  Ciro Martins Gomes; Natália Aparecida de Paula; Orlando Oliveira de Morais; Killarney Ataíde Soares; Ana Maria Roselino; Raimunda Nonata Ribeiro Sampaio
Journal:  An Bras Dermatol       Date:  2014 Sep-Oct       Impact factor: 1.896

4.  Tegumentary leishmaniasis diagnosis: what happened with MST (Montenegro Skin Test) in Brazil?

Authors:  Lucia Maria Almeida Braz
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2019-03-11       Impact factor: 1.846

5.  Cross-Reactivity Using Chimeric Trypanosoma cruzi Antigens: Diagnostic Performance in Settings Where Chagas Disease and American Cutaneous or Visceral Leishmaniasis Are Coendemic.

Authors:  Ramona Tavares Daltro; Leonardo Maia Leony; Natália Erdens Maron Freitas; Ângelo Antônio Oliveira Silva; Emily Ferreira Santos; Rodrigo Pimenta Del-Rei; Maria Edileuza Felinto Brito; Sinval Pinto Brandão-Filho; Yara Miranda Gomes; Marcelo Sousa Silva; Silvia Tavares Donato; Selma Maria Bezerra Jeronimo; Gloria Regina de Góis Monteiro; Lucas Pedreira Carvalho; Andréa Santos Magalhães; Nilson Ivo Tonin Zanchin; Paola Alejandra Fiorani Celedon; Fred Luciano Neves Santos
Journal:  J Clin Microbiol       Date:  2019-07-26       Impact factor: 5.948

6.  Leishmania V. braziliensis infection in asymptomatic domestic animals within an endemic region in the Northeast of Brazil.

Authors:  Claudio Júlio da Silva; Karina Patricia Baracho Lima; Juliana Figueirêdo da Costa Lima Suassuna Monteiro; Andréa Karla Sales Ferreira da Silva; Fernando José da Silva; Allana Maria de Souza Pereira; Valéria Pereira Hernandes; Elis Dionísio da Silva; Cláudia Sofia de Assunção Gonçalves E Silva; Sinval Pinto Brandão Filho; Maria Edileuza Felinto de Brito
Journal:  Rev Soc Bras Med Trop       Date:  2022-08-12       Impact factor: 2.141

7.  Applicability of kDNA-PCR for routine diagnosis of American tegumentary leishmaniasis in a tertiary reference hospital.

Authors:  Marcela M Satow; Edite H Yamashiro-Kanashiro; Mussya C Rocha; Luiza K Oyafuso; Rita C Soler; Paulo C Cotrim; José Angelo L Lindoso
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2013 Nov-Dec       Impact factor: 1.846

8.  Montenegro skin test and age of skin lesion as predictors of treatment failure in cutaneous leishmaniasis.

Authors:  Liliane de Fátima Antonio; Aline Fagundes; Raquel Vasconcellos Carvalhaes Oliveira; Priscila Garcia Pinto; Sandro Javier Bedoya-Pacheco; Erica de Camargo Ferreira e Vasconcellos; Maria Cláudia Valete-Rosalino; Marcelo Rosandiski Lyra; Sônia Regina Lambert Passos; Maria Inês Fernandes Pimentel; Armando de Oliveira Schubach
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2014 Sep-Oct       Impact factor: 1.846

9.  Field validation of a Leishmania (Leishmania) mexicana exo-antigens ELISA for diagnosing tegumentary leishmaniasis in regions of Leishmania (Viannia) predominance.

Authors:  Killarney Ataide Soares; Ada Amália Ayala Urdapilleta; Gilcilene Maria dos Santos; Andréa Lisboa Carneiro; Ciro Martins Gomes; Ana Maria Roselino; Raimunda Nonata Ribeiro Sampaio
Journal:  Braz J Infect Dis       Date:  2015-05-15       Impact factor: 3.257

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.